NeuroD1-induced fate conversion partially restores GABAergic neuronal identity in Huntington’s disease
Molecular Therapy · 2026-11
DOI: 10.1016/j.ymthe.2026.10.032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2026-11. Verfasst von Siwoo Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea; Graduate Program…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Ministry of Health and Welfare, Korea Health Industry Development Institute, Korea Ministry of Science and ICT.
Abstract (Originalsprache)
NeuroD1 is a master transcription factor governing neuronal differentiation and subtype specification, yet its potential to restore striatal identity in Huntington's disease (HD) remains unresolved. In HD, striosomal D2 striatal projection neurons (SPNs) represent the earliest and most selectively vulnerable population, leading to early collapse of striatal compartmental organization. Here, we show that astrocyte-targeted expression of NeuroD1, via AAV9-mediated delivery of NeuroD1 under the GFAP promoter in a transgenic murine model of HD, reinstates hallmarks of inhibitory neuronal maturation, synaptic proteins, and chloride homeostasis in the striatum. Single-nucleus RNA sequencing further revealed selective recovery of striosomal D2 transcriptional programs and compartment-specific molecular signatures. NeuroD1 treatment promoted the partial reorganization of striosome-matrix compartmental distinctions, including the restoration of MOR1-defined striosomal domains. These cellular and circuit-level restorations were accompanied by significant amelioration of functional deficits in motor coordination and clasping behaviors. Together, these findings establish astroglial NeuroD1-mediated identity reinforcement as a potential strategy to counter subtype- and compartment-specific circuit disintegration in HD.
Autor:innen und Institutionen
- Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea; Graduate Program of Biomedical Engineering, Yonsei University College of Medicine, Seo…
- Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea; Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College…
- Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea; Department of Biohealth Engineering, Graduate School of Transdisciplinary Health Scien…
Förderung
- Korea Ministry of Health and Welfare
- Korea Health Industry Development Institute
- Korea Ministry of Science and ICT
Zitieren
APA
Lee, S., Notario, G. R., Seo, J. H., & Cho, S. R. (2026). NeuroD1-induced fate conversion partially restores GABAergic neuronal identity in Huntington’s disease. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2026.10.032
Vancouver
Lee S, Notario GR, Seo JH, Cho SR. NeuroD1-induced fate conversion partially restores GABAergic neuronal identity in Huntington’s disease. Molecular Therapy. 2026. doi:10.1016/j.ymthe.2026.10.032
BibTeX
@article{Lee2026,
author = {Lee, Siwoo and Notario, Geneva Rose and Seo, Jung Hwa and Cho, Sung-Rae},
title = {NeuroD1-induced fate conversion partially restores GABAergic neuronal identity in Huntington’s disease},
journal = {Molecular Therapy},
year = {2026},
doi = {10.1016/j.ymthe.2026.10.032}
}
EUVIMED